<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-10190</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0070793</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Theoretical biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Mathematics</subject><subj-group><subject>Nonlinear dynamics</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Immunity</subject><subj-group><subject>Vaccination</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Non-clinical medicine</subject><subj-group><subject>Health economics</subject><subj-group><subject>Cost effectiveness</subject></subj-group></subj-group><subj-group><subject>Socioeconomic aspects of health</subject></subj-group></subj-group><subj-group><subject>Public health</subject><subj-group><subject>Socioeconomic aspects of health</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics</subject><subj-group><subject>Interdisciplinary physics</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Evaluating Roles of Nodes in Optimal Allocation of Vaccines with Economic Considerations</article-title>
<alt-title alt-title-type="running-head">Optimal Allocation of Vaccines</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Suzuki</surname><given-names>Hideyuki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aihara</surname><given-names>Kazuyuki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>FIRST, Aihara Innovative Mathematical Modelling Project, Japan Science and Technology Agency, Meguro-ku, Tokyo, Japan</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Institute of Industrial Science, The University of Tokyo, Meguro-ku, Tokyo, Japan</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>PRESTO, Japan Science and Technology Agency (JST), Kawaguchi, Saitama, Japan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Hayasaka</surname><given-names>Satoru</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Wake Forest School of Medicine, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">bingbignmath@gmail.com</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: BW HS KA. Performed the experiments: BW. Analyzed the data: BW HS KA. Contributed reagents/materials/analysis tools: BW HS KA. Wrote the paper: BW HS KA.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>14</day><month>8</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>8</issue>
<elocation-id>e70793</elocation-id>
<history>
<date date-type="received"><day>8</day><month>3</month><year>2013</year></date>
<date date-type="accepted"><day>25</day><month>6</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Wang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Since the allocation of vaccines is often constrained by limited resources, designing an economical vaccination strategy is a fundamental goal of the epidemiological modelling. In this study, with the objective of reducing costs, we determine the optimal allocation of vaccines for a general class of infectious diseases that spread mainly via contact. We use an optimization routine to identify the roles of nodes with distinct degrees as depending on the cost of treatment to that of vaccination (<italic>relative cost of treatment</italic>). The optimal allocation drives vaccination priority to medium-degree nodes at a low relative cost of treatment or to high-degree nodes at a high relative cost of treatment. According to the presented results, we may adjust the vaccination priority in the face of an endemic situation.</p>
</abstract>
<funding-group><funding-statement>This research is supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the “Funding Program for World-Leading Innovative R&amp;D on Science and Technology (FIRST Program),” initiated by the Council for Science and Technology Policy (CSTP) (BW, HS, and KA), as well as the program by the Japan Science and Technology Agency (JST) “Precursory Research for Embryonic Science and Technology (PRESTO) program” (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Vaccines are often used to combat specific diseases, thereby preventing millions of deaths every year. Mathematical modelling of vaccine policies <xref ref-type="bibr" rid="pone.0070793-Shulgin1">[1]</xref> and the human behavior that influences epidemic dynamics <xref ref-type="bibr" rid="pone.0070793-Bauch1">[2]</xref>–<xref ref-type="bibr" rid="pone.0070793-Wang1">[7]</xref> have attracted considerable attention during the last few years. In order to control the outbreak of an infectious disease efficiently, a reasonable vaccination strategy is required, and its efficacy needs to be evaluated. To this end, the characteristics of an infectious disease often provide important guidelines for the determination of the optimal allocation of vaccines <xref ref-type="bibr" rid="pone.0070793-Miller1">[8]</xref>. For instance, a strategy that takes into account the transmission rates of the influenza virus in different age groups and targets the group with the highest risk of infection, i.e., schoolchildren, has achieved the largest reduction in transmission <xref ref-type="bibr" rid="pone.0070793-Wallinga1">[9]</xref>, <xref ref-type="bibr" rid="pone.0070793-Medlock1">[10]</xref>. The efficacy of a vaccination strategy has often been evaluated by comparing it with other vaccination strategies that aim at reducing the transmission rate or infection risk <xref ref-type="bibr" rid="pone.0070793-Liu1">[11]</xref>. However, a comparative analysis of different strategies is not sufficient for finding the optimal strategy <xref ref-type="bibr" rid="pone.0070793-Medlock1">[10]</xref>. Given certain outcome measures, such as the basic reproduction number <xref ref-type="bibr" rid="pone.0070793-Becker1">[12]</xref>, <xref ref-type="bibr" rid="pone.0070793-Hill1">[13]</xref>, and the morbidity and mortality rates of a disease <xref ref-type="bibr" rid="pone.0070793-Bansal1">[14]</xref>, <xref ref-type="bibr" rid="pone.0070793-Tuite1">[15]</xref>, and the economic considerations <xref ref-type="bibr" rid="pone.0070793-Klepac1">[16]</xref>, the optimal allocation of vaccines can be determined accordingly using an optimization procedure <xref ref-type="bibr" rid="pone.0070793-Patel1">[17]</xref>, <xref ref-type="bibr" rid="pone.0070793-Manski1">[18]</xref>. Since the available amount of vaccines is often limited, economic factors become fundamentally important. Thus, the requirement for a successful strategy would primarily involve the minimization of the total cost, and it might be more desirable to rely on the design of an economical vaccine policy.</p>
<p>For airborne diseases, such as the influenza virus, the assumption of a homogeneous mixing of the population is often reasonable for modeling the epidemic dynamics. However, for contagious diseases, such as sexually transmitted diseases (STDs), it may not be appropriate. This is because the sexual contact network within a population has been found to obey power-law degree distribution <xref ref-type="bibr" rid="pone.0070793-Latora1">[19]</xref>, wherein heterogeneity in the network leads to the epidemic process being characterized by new properties, such as the vanishing of the critical invasion threshold in the limit of infinite population <xref ref-type="bibr" rid="pone.0070793-PastorSatorras1">[20]</xref>, <xref ref-type="bibr" rid="pone.0070793-PastorSatorras2">[21]</xref>. Consequently, heterogeneity leads to new intervention strategies <xref ref-type="bibr" rid="pone.0070793-PastorSatorra1">[22]</xref>–<xref ref-type="bibr" rid="pone.0070793-Wang2">[24]</xref>, such as targeting vaccination at highly connected nodes <xref ref-type="bibr" rid="pone.0070793-Latora1">[19]</xref>.</p>
<p>Supposing that a fixed amount of vaccine is available, how to allocate it efficiently in the population is an essential issue with which public health officials are often concerned <xref ref-type="bibr" rid="pone.0070793-Forster1">[25]</xref>, <xref ref-type="bibr" rid="pone.0070793-Kleczkowski1">[26]</xref>. Cost may be used to treat infected individuals, and it may be used to vaccinate susceptible individuals. The issue of minimizing the total costs of both treatment and vaccination, similar to the issue presented here, was explored in <xref ref-type="bibr" rid="pone.0070793-Klepac1">[16]</xref>, where the network was assumed to be homogeneous, and thereby, nodes were equivalently treated. However, previous studies have shown that, depending on the detailed dynamics, nodes with distinct degrees play diverse roles. For instance, hub nodes play a crucial role in maintaining the static network robustness <xref ref-type="bibr" rid="pone.0070793-Wang2">[24]</xref>, whereas low-degree nodes are important for maintaining the dynamical network robustness <xref ref-type="bibr" rid="pone.0070793-Tanaka1">[27]</xref>.</p>
<p>In this paper, we are concerned with the role of nodes with distinct degrees in the design of an economical vaccination strategy. It may be useful to consider the factor of heterogeneity in different aspects of diseases, such as susceptibility, infectiousness, and latent and incubation periods; however, we focus particularly on the importance of contact. To achieve our objective of describing a general class of diseases that predominantly spread via contact, in this study we utilized a susceptible-infected-recovered (SIR) model and ignored side effects possibly caused by treatment, vaccination, and so on. The pursuit of the optimal allocation of vaccines that balances the trade-off between vaccination and treatment leads us to make the simple assumption that all infected individuals may receive treatment, and thus, the issue of the optimal ratio of individuals who receive treatment is beyond the scope of this paper. For further detailed analysis of this issue, please refer to Ref. <xref ref-type="bibr" rid="pone.0070793-Forster1">[25]</xref>. In addition, in order to observe explicitly the relationship between vaccination and treatment, the endemic state of the disease in the long run is used, and consequently, this assumption constrains our study to the control of endemic situations and not to the control of emerging outbreaks.</p>
<p>In the study, we assume that a fixed amount of vaccines is provided at each time unit. Based on the epidemiological model that uses births and deaths, we investigate the optimal vaccination strategies in two cases: (i) homogeneous networks; (ii) heterogeneous networks. We find that in case (i), depending on the cost of treatment relative to that of vaccination (relative cost of treatment), optimal vaccination coverage varies between zero and the critical coverage required to eradicate the disease. In case (ii), it becomes almost impossible to derive the optimal allocation analytically, because the allocation of vaccine is uncertain and the number of variables involved in the model is increased. We use an optimization routine named <italic>tabu search</italic>, to obtain numerically the optimal allocations within a range of parameters. In the light of our findings, the optimal allocation is closely relevant to the relative cost of treatment. In the case of a low relative cost of treatment, vaccination priority usually goes to medium-degree nodes rather than high-degree nodes, which indicates that the role of high-degree nodes may have to be reevaluated; however, in the case of a high relative cost of treatment, vaccination priority may shift primarily toward high-degree nodes, where the reduction in the fraction of infected nodes crucially affects how much the total cost will be. This study may guide us to determine the optimal allocation of vaccines for a general class of infectious diseases that spread mainly via contact, and it may provide important insights into the role of nodes in the economical control of infectious disease, which will benefit public health services.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Case of homogeneous networks</title>
<p>The theoretical understanding of the spread of epidemics is usually based on compartmental models, in which individuals in the population are classified into a discrete set of states and mixed homogeneously. In order to carry out the epidemiological analysis, the basic susceptible-infected-removed (SIR) model that uses births and deaths was employed, where the birth and death rates are assumed to be equal to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e001" xlink:type="simple"/></inline-formula>. This model assumes that the time scale of an epidemic is longer than the demographic time scale. Unvaccinated susceptible individuals become infected by coming in contact with infectious individuals at the rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e002" xlink:type="simple"/></inline-formula>, and infected individuals undergo recovery at rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e003" xlink:type="simple"/></inline-formula>. We assumed that a fixed vaccination coverage, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e004" xlink:type="simple"/></inline-formula>, is provided at each time unit, even after the eradication of the disease. Since vaccines rarely provide full protection from diseases <xref ref-type="bibr" rid="pone.0070793-Gandon1">[28]</xref>, partially effective (imperfect) vaccines are often used to protect both individuals and the entire population, as is the case for vaccines currently being developed against malaria <xref ref-type="bibr" rid="pone.0070793-Hoffman1">[29]</xref> and the human immunodeficiency virus (HIV) <xref ref-type="bibr" rid="pone.0070793-Blower1">[30]</xref>. Thus, the assumption of a partially effective vaccine was made in the model. The vaccine efficacy, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e005" xlink:type="simple"/></inline-formula>, is captured by a reduced infection rate, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e006" xlink:type="simple"/></inline-formula>, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e007" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e008" xlink:type="simple"/></inline-formula>, at which vaccinated individuals become infected.</p>
<p>Without economic considerations, the critical vaccination coverage, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e009" xlink:type="simple"/></inline-formula>, i.e., the fraction of the population that has to be vaccinated to avoid a major outbreak, should satisfy the condition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e010" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e011" xlink:type="simple"/></inline-formula> denotes the basic reproduction number, defined as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e012" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pone.0070793-Diekmann1">[31]</xref>. Thus, the critical vaccination coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e013" xlink:type="simple"/></inline-formula> is derived as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e014" xlink:type="simple"/></inline-formula>, indicating that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e015" xlink:type="simple"/></inline-formula> decreases with an increase in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e016" xlink:type="simple"/></inline-formula> and increases with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e017" xlink:type="simple"/></inline-formula>. In particular, if <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e018" xlink:type="simple"/></inline-formula>, vaccination will lead to the eradication of the disease.</p>
<p>Let us consider the cost associated with the model. Suppose that the total cost is composed of two parts: The cost of vaccinating susceptible individuals and that of treating infected individuals. Obviously, vaccinating susceptible individuals will increase with the amount of vaccines used. For simplicity, we assume that the cost of vaccination exponentially depends on the vaccination coverage, as in Ref. <xref ref-type="bibr" rid="pone.0070793-Klepac1">[16]</xref>, whereas the cost of treatment is proportional to the prevalence of the disease. In this study, discounting was ignored and the cost was counted only at the end of an epidemic <xref ref-type="bibr" rid="pone.0070793-Klepac1">[16]</xref>. Therefore, the total cost is defined as<disp-formula id="pone.0070793.e019"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e019" xlink:type="simple"/><label>(1)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e020" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e021" xlink:type="simple"/></inline-formula> denote the stationary fractions of susceptible and infected nodes, respectively, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e022" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e023" xlink:type="simple"/></inline-formula> denote the per capita cost of vaccination and that of treatment, respectively. Typically, we have <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e024" xlink:type="simple"/></inline-formula> (where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e025" xlink:type="simple"/></inline-formula> is referred to as the “relative cost of treatment”), indicating that the lower cost of vaccination would save us money as compared to the perceived high cost of treatment. The optimal solution to Eq. (1) is achieved by validating the first-order condition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e026" xlink:type="simple"/></inline-formula> and given by<disp-formula id="pone.0070793.e027"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e027" xlink:type="simple"/><label>(2)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e028" xlink:type="simple"/></inline-formula> should satisfy the condition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e029" xlink:type="simple"/></inline-formula> for a meaningful solution to exist. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e030" xlink:type="simple"/></inline-formula> is a local minimal solution that is further confirmed by checking the second-order condition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e031" xlink:type="simple"/></inline-formula> (see Methods).</p>
<p><xref ref-type="fig" rid="pone-0070793-g001">Figure 1</xref> shows the total cost (the black solid lines), the cost of treatment (the red dashed lines), and that of vaccination (the blue short dashed line) versus <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e032" xlink:type="simple"/></inline-formula>. Obviously, the cost of treatment decreases with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e033" xlink:type="simple"/></inline-formula>, because the more available is the vaccination coverage, the smaller is the fraction of infected nodes at equilibrium. At <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e034" xlink:type="simple"/></inline-formula>, the outbreak is almost eradicated. If vaccines are continually provided, the cost of treatment decreases to zero, while the cost of vaccination increases continually (see the blue short dashed line in <xref ref-type="fig" rid="pone-0070793-g001">Fig. 1</xref>). Therefore, the total cost varies irregularly with the relative cost of treatment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e035" xlink:type="simple"/></inline-formula>, yielding a minimal solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e036" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e037" xlink:type="simple"/></inline-formula>).</p>
<fig id="pone-0070793-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g001</object-id><label>Figure 1</label><caption>
<title>Cost versus <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e038" xlink:type="simple"/></inline-formula>for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e039" xlink:type="simple"/></inline-formula> (from bottom to top) in homogeneous networks.</title>
<p>(The green dotted vertical line) the theoretical solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e040" xlink:type="simple"/></inline-formula>; (the blue short dashed line) the cost of vaccination; (the red dashed lines) the cost of treatment; and (the black solid lines) the total cost. Parameters are set as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e041" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e042" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e043" xlink:type="simple"/></inline-formula>. The basic per capita cost is set as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e044" xlink:type="simple"/></inline-formula> and the vaccine efficacy is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e045" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g001" position="float" xlink:type="simple"/></fig>
<p>The total cost as a function of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e046" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e047" xlink:type="simple"/></inline-formula> with regard to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e048" xlink:type="simple"/></inline-formula> is shown in <xref ref-type="fig" rid="pone-0070793-g002">Fig. 2</xref>. The curves indicate that the optimal vaccination coverage is closely related to the relative cost of treatment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e049" xlink:type="simple"/></inline-formula> and the vaccine efficacy <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e050" xlink:type="simple"/></inline-formula>. For example, if the vaccine efficacy is high (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e051" xlink:type="simple"/></inline-formula>) and the relative cost of treatment is low (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e052" xlink:type="simple"/></inline-formula>), it is unnecessary to vaccinate any nodes at all; on the other hand, with an increase in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e053" xlink:type="simple"/></inline-formula>, vaccines are required in order to reduce the prevalence of the epidemic (<xref ref-type="fig" rid="pone-0070793-g002">Fig. 2</xref> (a)). With a reduction in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e054" xlink:type="simple"/></inline-formula>, it would be more economical to stop vaccination (<xref ref-type="fig" rid="pone-0070793-g002">Fig. 2</xref> (c)).</p>
<fig id="pone-0070793-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g002</object-id><label>Figure 2</label><caption>
<title>The total cost versus <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e055" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e056" xlink:type="simple"/></inline-formula> for different vaccine efficacy <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e057" xlink:type="simple"/></inline-formula>. (a) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e058" xlink:type="simple"/></inline-formula>; (b) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e059" xlink:type="simple"/></inline-formula>; and (c) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e060" xlink:type="simple"/></inline-formula>.</title>
<p>Circles indicate the optimal vaccine coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e061" xlink:type="simple"/></inline-formula> for each value of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e062" xlink:type="simple"/></inline-formula>. Other parameters are set to the same values as in Fig. 1.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g002" position="float" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>Case of heterogeneous networks</title>
<p>In order to understand the role of nodes in the epidemic process with regard to vaccination, we investigated the optimal allocation of vaccines in heterogeneous networks, where the degree distribution follows power-law, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e063" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e064" xlink:type="simple"/></inline-formula>) with a finite average connectivity <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e065" xlink:type="simple"/></inline-formula>. Since only a fraction <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e066" xlink:type="simple"/></inline-formula> of the population at most can receive vaccines, achieving an efficient allocation at relatively low cost is an essential goal in the design of a public health strategy. Intuitively, a simple and direct design should account for nodes' degrees, that is, for each degree-block <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e067" xlink:type="simple"/></inline-formula>, a fraction <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e068" xlink:type="simple"/></inline-formula> of the population with degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e069" xlink:type="simple"/></inline-formula> at most will receive vaccines. Therefore, the problem is to search the optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e070" xlink:type="simple"/></inline-formula> that minimizes the total cost subject to the constraint that the total consumption of vaccination is not more than the total resources, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e071" xlink:type="simple"/></inline-formula>.</p>
<p>Let us first investigate how the critical infection rate varies versus vaccine allocation in heterogeneous networks. With the mean-field approximation for each degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e072" xlink:type="simple"/></inline-formula> (see Methods), the effective infection rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e073" xlink:type="simple"/></inline-formula> is given by<disp-formula id="pone.0070793.e074"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e074" xlink:type="simple"/><label>(3)</label></disp-formula>which relates the network topology (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e075" xlink:type="simple"/></inline-formula>) to the second moment of the vaccine allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e076" xlink:type="simple"/></inline-formula>, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e077" xlink:type="simple"/></inline-formula>. <xref ref-type="disp-formula" rid="pone.0070793.e074">Equation (3</xref>) indicates that the critical infection rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e078" xlink:type="simple"/></inline-formula> is determined by the network structure only before and after vaccination.</p>
</sec><sec id="s2c">
<title>Optimal allocation of vaccines in uncorrelated networks</title>
<p>In this study, instead of simply comparing a number of typical vaccination strategies, such as target <xref ref-type="bibr" rid="pone.0070793-Cohen2">[32]</xref>, random <xref ref-type="bibr" rid="pone.0070793-Wang2">[24]</xref>, and acquaintance vaccination <xref ref-type="bibr" rid="pone.0070793-Cohen1">[23]</xref>, we directly performed an optimization routine to determine the optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e079" xlink:type="simple"/></inline-formula>. As demonstrated by previous efforts <xref ref-type="bibr" rid="pone.0070793-Cohen2">[32]</xref>, targeting vaccination at hub nodes can efficiently eradicate the outbreak, but it is unknown if this strategy is still optimal in terms of economical considerations. In order to highlight the role of nodes with high degrees, nodes with degree larger than a certain critical value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e080" xlink:type="simple"/></inline-formula> are stratified into one group, whereas nodes with the same degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e081" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e082" xlink:type="simple"/></inline-formula>), namely <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e083" xlink:type="simple"/></inline-formula>, are stratified into the same groups. Consequently, nodes in the same group receive the same percentage of vaccines. For example, according to the degree distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e084" xlink:type="simple"/></inline-formula>, nodes can be stratified into eight groups as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e085" xlink:type="simple"/></inline-formula>, {3},...,<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e086" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e087" xlink:type="simple"/></inline-formula> denotes the minimal degree and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e088" xlink:type="simple"/></inline-formula> denotes the maximal degree. Subsequently, high-degree nodes are separated from the other nodes, and their role in the optimal allocation can be clarified.</p>
<p>The optimization problem of allocating vaccines in heterogeneous networks is described as<disp-formula id="pone.0070793.e089"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e089" xlink:type="simple"/><label>(4)</label></disp-formula></p>
<p>Obviously, the total number of vaccinated nodes <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e090" xlink:type="simple"/></inline-formula> should not be greater than the total vaccine resources allocated to each degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e091" xlink:type="simple"/></inline-formula>, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e092" xlink:type="simple"/></inline-formula>. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e093" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e094" xlink:type="simple"/></inline-formula> denote the fractions of susceptible and infected nodes at equilibrium, respectively. The objective function <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e095" xlink:type="simple"/></inline-formula> is composed of two components, the cost of vaccination, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e096" xlink:type="simple"/></inline-formula>, and that of treatment, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e097" xlink:type="simple"/></inline-formula>, as seen in Eq. (4).</p>
<p>Using the tabu search <xref ref-type="bibr" rid="pone.0070793-Glover1">[33]</xref>, we determined the optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e098" xlink:type="simple"/></inline-formula> for the minimal cost <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e099" xlink:type="simple"/></inline-formula> with regard to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e100" xlink:type="simple"/></inline-formula>. Intuitively, if the per capita cost of treatment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e101" xlink:type="simple"/></inline-formula> is high, more doses of vaccines are required to reduce the fraction of infected nodes, and vice versa. We performed the tabu search with 10 different initial solutions and chose the one with the lowest cost as the optimal solution.</p>
<p>We begin by testing networks generated using the uncorrelated configuration network model with a given degree distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e102" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e103" xlink:type="simple"/></inline-formula>) <xref ref-type="bibr" rid="pone.0070793-Molloy1">[34]</xref> (see Methods). This will produce the maximal degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e104" xlink:type="simple"/></inline-formula>, and the degree correlation is avoided. When networks have been generated, the conditional probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e105" xlink:type="simple"/></inline-formula> that a node with degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e106" xlink:type="simple"/></inline-formula> is connected to a node with degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e107" xlink:type="simple"/></inline-formula> is determined. Due to the uncertainty in the allocation of vaccines to the nodes with degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e108" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e109" xlink:type="simple"/></inline-formula>, it is difficult to derive the explicit forms of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e110" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e111" xlink:type="simple"/></inline-formula> at equilibrium in the present model. Thus, we numerically calculate them with the model in Eqs. (10) and (11) (see Methods).</p>
<p>In order to understand the impact of the relative cost of treatment <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e112" xlink:type="simple"/></inline-formula> on the optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e113" xlink:type="simple"/></inline-formula>, we performed the optimization routine for a low relative cost of treatment (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e114" xlink:type="simple"/></inline-formula>) and high relative cost of treatment (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e115" xlink:type="simple"/></inline-formula>), respectively. Without loss of generality, in the following, vaccines are assumed to be perfect, that is, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e116" xlink:type="simple"/></inline-formula>. Moreover, to understand the characteristics that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e117" xlink:type="simple"/></inline-formula> possesses, we recorded the distribution of vaccinated nodes for each degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e118" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e119" xlink:type="simple"/></inline-formula>, given by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e120" xlink:type="simple"/></inline-formula>, and the distribution of the fraction of infected nodes at equilibrium, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e121" xlink:type="simple"/></inline-formula>. Comparing the optimal allocations <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e122" xlink:type="simple"/></inline-formula> with regard to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e123" xlink:type="simple"/></inline-formula>, we found a significant difference between them. For a low relative cost of treatment (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e124" xlink:type="simple"/></inline-formula>), the optimal allocation vaccinates fewer nodes with extremely high degrees and low degrees (<xref ref-type="fig" rid="pone-0070793-g003">Fig. 3</xref> (a) and (d)). For example, only <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e125" xlink:type="simple"/></inline-formula> of nodes with degree larger than 30 are vaccinated, and nodes with degree less than 10 are not vaccinated. The result suggests that, for low relative cost of treatment, solely targeting vaccination at high-degree nodes may be considerably less economical.</p>
<fig id="pone-0070793-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g003</object-id><label>Figure 3</label><caption>
<title>Comparison of optimal allocations of vaccines with target vaccination in uncorrelated scale-free networks.</title>
<p>Optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e126" xlink:type="simple"/></inline-formula> (a), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e127" xlink:type="simple"/></inline-formula> (d), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e128" xlink:type="simple"/></inline-formula> (g) for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e129" xlink:type="simple"/></inline-formula> (left column); optimal allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e130" xlink:type="simple"/></inline-formula> (b), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e131" xlink:type="simple"/></inline-formula> (e), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e132" xlink:type="simple"/></inline-formula> (h) for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e133" xlink:type="simple"/></inline-formula> (center column); target allocation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e134" xlink:type="simple"/></inline-formula> (c), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e135" xlink:type="simple"/></inline-formula> (f), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e136" xlink:type="simple"/></inline-formula> (i) (right column). At equilibrium, the fractions of infected nodes are <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e137" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e138" xlink:type="simple"/></inline-formula>), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e139" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e140" xlink:type="simple"/></inline-formula>), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e141" xlink:type="simple"/></inline-formula> (target vaccination), respectively. The total costs for the optimal allocation are <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e142" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e143" xlink:type="simple"/></inline-formula>), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e144" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e145" xlink:type="simple"/></inline-formula>), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e146" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e147" xlink:type="simple"/></inline-formula> for target vaccination), and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e148" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e149" xlink:type="simple"/></inline-formula> for target vaccination). <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e150" xlink:type="simple"/></inline-formula> and the maximal vaccination coverage is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e151" xlink:type="simple"/></inline-formula>. The degree distribution is generated with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e152" xlink:type="simple"/></inline-formula> and the network size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e153" xlink:type="simple"/></inline-formula>. The minimal degree is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e154" xlink:type="simple"/></inline-formula> and the maximal degree is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e155" xlink:type="simple"/></inline-formula>. Nodes are grouped into 30 groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g003" position="float" xlink:type="simple"/></fig>
<p>With an increase in the relative cost of treatment (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e156" xlink:type="simple"/></inline-formula>, <xref ref-type="fig" rid="pone-0070793-g003">Fig. 3</xref>, center column), more high-degree nodes are vaccinated, e.g., most nodes with degree larger than 20 are vaccinated. This implies that, for the high relative cost considered in this analysis, targeting vaccination at high-degree nodes can efficiently reduce the fraction of infected nodes at equilibrium and the perceived cost of treatment as well. To understand the characteristics of the optimal allocation further, we compared them with those of target vaccination (<xref ref-type="fig" rid="pone-0070793-g003">Fig. 3</xref>, right column). Target vaccination is carried out by vaccinating all nodes with degree larger than some value (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e157" xlink:type="simple"/></inline-formula>). Properties, such as the distribution of vaccinated nodes, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e158" xlink:type="simple"/></inline-formula>, and the distribution of the fraction of infected nodes, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e159" xlink:type="simple"/></inline-formula>, are also shown in <xref ref-type="fig" rid="pone-0070793-g003">Fig. 3</xref>. A comparison of the optimal vaccination for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e160" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e161" xlink:type="simple"/></inline-formula> with target vaccination, revealed that when the relative cost of treatment is low, optimal allocation performs much better than target vaccination; when the relative cost of treatment is high, target vaccination performs nearly identically to optimal allocation. In the latter case, the reduction of infected nodes becomes crucial to that of the total cost. This is confirmed in <xref ref-type="fig" rid="pone-0070793-g003">Fig. 3</xref> (h), where fewer nodes are infected at equilibrium. Since, in practice, detailed knowledge of the optimal allocation is not often available in advance, targeting vaccination at high-degree nodes may be taken as an alternative strategy in this case.</p>
<p>The results presented above suggest that the design of an optimal allocation should take into account factors that include the relative cost of treatment. From a realistic point of view, it provides us with some insights into the design of an economical allocation of vaccines for the control of diseases that spread via contact. These diseases are typically characterized by sexually transmitted diseases (STDs), such as gonorrhea, chlamydia, and syphilis, where individuals are infected through sexual contact with an infectious person. Since the human sexual contact network follows power-law distribution <xref ref-type="bibr" rid="pone.0070793-Liljeros1">[35]</xref>, in light of our results, we speculate that if the cost of treating STDs is extremely high, people who have more sexual partners (hub individuals) should be prioritized for vaccination. Thus, the perceived high cost of treatment caused by the potential infection of hub individuals may be reduced. To this end, tracing individuals' sexual contacts to obtain precise knowledge concerning the people who are well connected in the sexual network, as was done in the Swedish survey of sexual behavior in 1996 <xref ref-type="bibr" rid="pone.0070793-Latora1">[19]</xref> is a fundamental requirement <xref ref-type="bibr" rid="pone.0070793-Huerta1">[36]</xref>. If the cost of treatment is not very high, precise knowledge of personal contacts may not be required.</p>
</sec><sec id="s2d">
<title>Optimal allocation of vaccines in correlated networks</title>
<p>The results presented above are based on the configuration network model where degree correlation is omitted; however, in the real world, networks often show some level of degree correlations <xref ref-type="bibr" rid="pone.0070793-Newman1">[37]</xref>. The degree correlation of a network can be quantified by the assortativity <xref ref-type="bibr" rid="pone.0070793-Newman1">[37]</xref><disp-formula id="pone.0070793.e162"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e162" xlink:type="simple"/><label>(5)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e163" xlink:type="simple"/></inline-formula> denotes the average over all links and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e164" xlink:type="simple"/></inline-formula> denotes the degrees of the two nodes at either end of the links. A positive (assortative) or negative (disassortative) degree correlation is denoted by the sign of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e165" xlink:type="simple"/></inline-formula>. An alternative method of calculating degree correlation is to measure the nearest neighbor degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e166" xlink:type="simple"/></inline-formula>, which is an increasing (decreasing) function of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e167" xlink:type="simple"/></inline-formula> for networks with a positive (negative) correlation. To generate networks with a desired degree correlation, we exchanged the end points of two edges chosen at random in uncorrelated networks until the desired degree correlation was achieved.</p>
<p>Optimal allocation of vaccines was then implemented on networks with typically positive and negative degree correlations (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e168" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e169" xlink:type="simple"/></inline-formula>, respectively); however, other parameters, such as network size and the average connectivity were the same as in uncorrelated networks, see <xref ref-type="fig" rid="pone-0070793-g004">Fig. 4</xref>. Irrespective of the degree correlations, we obtained results that are qualitatively similar to those on networks with no degree correlation. The findings represent an advanced step toward the understanding of the role of high-degree nodes in the design of an economical vaccine allocation. Depending on the relative cost of treatment, the role of high-degree nodes is particularly different, driving the optimal vaccination strategy into two scenarios. When the relative cost of treatment is low, the tradeoff between the costs of vaccination and treatment drives the system to vaccinate fewer nodes with high degrees. When the relative cost of treatment is high, primarily the fraction of infected nodes determines how much the total cost will be. Under this condition, prioritizing the vaccination of high-degree nodes is crucial to the reduction of the fraction of infected nodes and of the total cost as well.</p>
<fig id="pone-0070793-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g004</object-id><label>Figure 4</label><caption>
<title>Comparison of optimal allocations of vaccines <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e170" xlink:type="simple"/></inline-formula>in networks with different degree correlations <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e171" xlink:type="simple"/></inline-formula>.</title>
<p>(a) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e172" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e173" xlink:type="simple"/></inline-formula>; (b) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e174" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e175" xlink:type="simple"/></inline-formula>; (c) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e176" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e177" xlink:type="simple"/></inline-formula>; (d) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e178" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e179" xlink:type="simple"/></inline-formula>. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e180" xlink:type="simple"/></inline-formula> and the maximal vaccination coverage is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e181" xlink:type="simple"/></inline-formula>. Other parameters are set to the same values as in Fig. 3. Nodes are grouped into 30 groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g004" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s3">
<title>Discussion</title>
<p>In this study, we used a general mathematical model to evaluate the optimal allocation of vaccines by focusing on a heterogeneous contact structure and accounting for economic factors. In this framework, for homogeneous networks, the optimal vaccination coverage with minimal cost varies between zero and the critical coverage, depending on the relative cost of treatment, as well as the vaccine efficacy.</p>
<p>The epidemic model (SIR) we used is very simple, no heterogeneity related to diseases being considered, but our preliminary analysis of heterogeneity in contact clarifies the role of nodes with different degrees in the optimal allocation of vaccines. In heterogeneous networks, depending on the relative cost of treatment, the optimal allocation varies such that the tradeoff between the cost of vaccination and that of treatment is balanced. In the case of low relative cost of treatment, target vaccination may have been overestimated in the present model. With an increase in the relative cost of treatment, vaccination priority may shift toward nodes with high degrees. The comparison analysis shows that the optimal allocation is superior to target vaccination in terms of minimal total cost but not in terms of minimal prevalence, whereas target vaccination is superior to the optimal allocation in terms of reducing the prevalence but not of minimizing the cost.</p>
<p>For the definition of cost, following Ref. <xref ref-type="bibr" rid="pone.0070793-Klepac1">[16]</xref>, we assumed that the cost of vaccination is exponentially dependent on the ratio of vaccinated individuals, whereas the cost of treatment is linearly dependent on the ratio of treated individuals. It might be useful to consider disease-related costs, such as those of side effects of treatment, morbidity, mortality, and loss of productivity, which are related to details of a specific disease.</p>
<p>The results of our present study are particularly useful for guiding the optimal allocation of vaccines for diseases that predominantly spread via contact, i.e., STDs, where heterogeneity in contact dominates the epidemic dynamics. In the real world, the main aim of the public health policy is usually to minimize the outbreak of an infectious disease. These results may provide insights for planning future cost-aware strategies for multi-objective optimization of vaccination, such as simultaneously optimizing both the cost and prevalence, which will be the primary concern of public health officials.</p>
<p>Overall, our study demonstrates that the design of an economical allocation of vaccinations should incorporate a number of important factors involved in the model. It may be possible to achieve better control of STDs if advances in our understanding of the nodes' role in epidemiology and transmission dynamics can be integrated into future intervention strategies.</p>
</sec><sec id="s4" sec-type="methods">
<title>Methods</title>
<sec id="s4a">
<title>Derivation in homogeneous networks</title>
<p>We apply the mass-action assumption, where all individuals have the same contact rate, to obtain the epidemic dynamics for the SIR model with imperfect vaccines <xref ref-type="bibr" rid="pone.0070793-Funk1">[6]</xref>,<disp-formula id="pone.0070793.e212"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e212" xlink:type="simple"/></disp-formula><disp-formula id="pone.0070793.e213"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e213" xlink:type="simple"/></disp-formula><disp-formula id="pone.0070793.e214"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e214" xlink:type="simple"/><label>(6)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e215" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e216" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e217" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e218" xlink:type="simple"/></inline-formula> denote the proportions of susceptible, infected, and recovered individuals, respectively. In particular, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e219" xlink:type="simple"/></inline-formula> represents the case of the classic model without vaccination, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e220" xlink:type="simple"/></inline-formula> represents the case of perfect vaccines, where all vaccinated individuals obtain complete protection from infection. In the case where no vaccines are given, the basic reproductive number is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e221" xlink:type="simple"/></inline-formula>. The fractions of susceptible and infected individuals at equilibrium are subsequently given by</p>
<p><disp-formula id="pone.0070793.e222"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e222" xlink:type="simple"/><label>(7)</label></disp-formula><disp-formula id="pone.0070793.e223"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e223" xlink:type="simple"/><label>(8)</label></disp-formula>The total cost is composed of two parts: The cost of vaccinating susceptible individuals and the cost of treating infected individuals. Therefore, the total cost is written as<disp-formula id="pone.0070793.e224"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e224" xlink:type="simple"/><label>(9)</label></disp-formula></p>
<p>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e225" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e226" xlink:type="simple"/></inline-formula> denote the per capita cost of vaccination and that of treatment, respectively. By inserting Eqs. (7) and (8) into (9), the optimal solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e227" xlink:type="simple"/></inline-formula> can be derived as shown in Eq. (2).</p>
</sec><sec id="s4b">
<title>Derivation of effective infection rate in uncorrelated networks</title>
<p>In order to investigate the effective infection rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e228" xlink:type="simple"/></inline-formula> when vaccination is induced, we consider the time evolution of the magnitudes of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e229" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e230" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e231" xlink:type="simple"/></inline-formula>, which denote the densities of the susceptible, infected, and recovered vertices of degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e232" xlink:type="simple"/></inline-formula>, respectively. These variables are connected by means of the normalization condition, and at the mean-field level, they satisfy the following set of coupled differential equations <xref ref-type="bibr" rid="pone.0070793-PastorSatorras1">[20]</xref>, <xref ref-type="bibr" rid="pone.0070793-PastorSatorras2">[21]</xref><disp-formula id="pone.0070793.e233"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e233" xlink:type="simple"/><label>(10)</label></disp-formula><disp-formula id="pone.0070793.e234"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e234" xlink:type="simple"/><label>(11)</label></disp-formula><disp-formula id="pone.0070793.e235"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e235" xlink:type="simple"/><label>(12)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e236" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e237" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e238" xlink:type="simple"/></inline-formula> satisfy <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e239" xlink:type="simple"/></inline-formula>. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e240" xlink:type="simple"/></inline-formula> indicates the probability that a vertex is reached by following a randomly chosen link whose end node is infected, written as<disp-formula id="pone.0070793.e241"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e241" xlink:type="simple"/><label>(13)</label></disp-formula>When stationary conditions are imposed, the equilibrium of the model is given by</p>
<p><disp-formula id="pone.0070793.e242"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e242" xlink:type="simple"/><label>(14)</label></disp-formula><disp-formula id="pone.0070793.e243"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e243" xlink:type="simple"/><label>(15)</label></disp-formula><disp-formula id="pone.0070793.e244"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e244" xlink:type="simple"/><label>(16)</label></disp-formula></p>
<p>By inserting Eq. (14) into Eq. (13), we have<disp-formula id="pone.0070793.e245"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e245" xlink:type="simple"/><label>(17)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e246" xlink:type="simple"/></inline-formula> is a function of itself, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e247" xlink:type="simple"/></inline-formula> is always a trivial solution. If there exists a nonzero solution, the condition</p>
<p><disp-formula id="pone.0070793.e248"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e248" xlink:type="simple"/></disp-formula></p>
<p>should be satisfied, which is rewritten as<disp-formula id="pone.0070793.e249"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e249" xlink:type="simple"/></disp-formula></p>
<p>Then, the effective infection rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e250" xlink:type="simple"/></inline-formula> is derived as<disp-formula id="pone.0070793.e251"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0070793.e251" xlink:type="simple"/><label>(18)</label></disp-formula>which indicates that below <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e252" xlink:type="simple"/></inline-formula> the disease is eradicated from the network, and above it there is an endemic state. In addition, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e253" xlink:type="simple"/></inline-formula> depends on the first (second) moment of the degree distribution, the second moment of the vaccination distribution, and the vaccine efficacy <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e254" xlink:type="simple"/></inline-formula>. If there are no available vaccines, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e255" xlink:type="simple"/></inline-formula>, with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e256" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e257" xlink:type="simple"/></inline-formula>, indicating that any disease can spread in heterogeneous networks with the degree distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e258" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e259" xlink:type="simple"/></inline-formula>). With the introduction of vaccines, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e260" xlink:type="simple"/></inline-formula> transforms to an explicit function in the form of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e261" xlink:type="simple"/></inline-formula>. In real-world networks, with a finite value of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e262" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e263" xlink:type="simple"/></inline-formula> increases with the vaccine efficacy <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e264" xlink:type="simple"/></inline-formula>, and thus, highly efficient vaccines may halt the spread of an infectious disease.</p>
</sec><sec id="s4c">
<title>Derivation of optimal allocation of vaccines in uncorrelated networks</title>
<p>It should be noted that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e265" xlink:type="simple"/></inline-formula> cannot be explicitly defined because it is not easy to solve <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e266" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e267" xlink:type="simple"/></inline-formula> analytically due to the complexity of heterogeneity in the network structure and the uncertainty of vaccine allocation in each block <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e268" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e269" xlink:type="simple"/></inline-formula>. Thus, we numerically solve <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e270" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e271" xlink:type="simple"/></inline-formula> using Eqs. (10) and (11). In order to solve the optimization problem, a heuristic algorithm named tabu search is subsequently implemented <xref ref-type="bibr" rid="pone.0070793-Glover1">[33]</xref>, <xref ref-type="bibr" rid="pone.0070793-Glover2">[38]</xref>–<xref ref-type="bibr" rid="pone.0070793-Wang3">[41]</xref> with 10 different initial solutions. Then, we choose the solution with the minimal cost among the 10 runs as the optimal solution. Finally, the optimal solution is further improved by taking the optimal solution previously obtained as an initial solution to start the tabu search again.</p>
<p>The processes of the tabu search for solving Eq. (4) are described as:</p>
<list list-type="bullet"><list-item>
<p>Step 1: Generate an initial feasible vector <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e272" xlink:type="simple"/></inline-formula> that satisfies the inequality constraints, and set the optimal solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e273" xlink:type="simple"/></inline-formula>, and calculate the optimal cost value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e274" xlink:type="simple"/></inline-formula>. Set the time step <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e275" xlink:type="simple"/></inline-formula>.</p>
</list-item><list-item>
<p>Step 2: Stop and output the optimal solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e276" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e277" xlink:type="simple"/></inline-formula> if a prescribed condition is satisfied; otherwise, generate a random vector <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e278" xlink:type="simple"/></inline-formula> that is feasible, and calculate the total cost <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e279" xlink:type="simple"/></inline-formula>.</p>
</list-item><list-item>
<p>Step 3: Update the optimal solution if <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e280" xlink:type="simple"/></inline-formula> as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e281" xlink:type="simple"/></inline-formula>. If <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e282" xlink:type="simple"/></inline-formula> or if <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e283" xlink:type="simple"/></inline-formula> does not satisfy the tabu conditions, set <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e284" xlink:type="simple"/></inline-formula>; else set <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e285" xlink:type="simple"/></inline-formula>. Set <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e286" xlink:type="simple"/></inline-formula> and return to step 2.</p>
</list-item></list>
<p>The condition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e287" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e288" xlink:type="simple"/></inline-formula> denotes the ratio of improvement or destruction that will be accepted if the new move is accepted, is used to determine whether a move is tabu. Thus, the new solution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e289" xlink:type="simple"/></inline-formula> in Step 2 is assumed tabu if the ratio of the total change in the objective function is larger than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e290" xlink:type="simple"/></inline-formula>. The terminal condition is that the present step reaches the predefined maximal number of iteration steps. Here, the maximal number of iteration steps is set as 2000.</p>
</sec><sec id="s4d">
<title>Configuration network models</title>
<p>In order to avoid degree correlation, the substrate networks are generated using the configuration model based on the Molloy-Reed algorithm <xref ref-type="bibr" rid="pone.0070793-Molloy1">[34]</xref>. Each vertex <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e291" xlink:type="simple"/></inline-formula> is assigned a degree <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e292" xlink:type="simple"/></inline-formula> from a given degree distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e293" xlink:type="simple"/></inline-formula>(<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e294" xlink:type="simple"/></inline-formula>), subject to the constraint <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e295" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e296" xlink:type="simple"/></inline-formula> indicates the network size.</p>
</sec><sec id="s4e">
<title>Sensitivity analyses</title>
<p>To explore the robustness of the results, we conducted sensitivity analyses with varied vaccination coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e297" xlink:type="simple"/></inline-formula> ranging from <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e298" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e299" xlink:type="simple"/></inline-formula>, while other parameters remained the same as given in the main text (without loss of generality, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e300" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e301" xlink:type="simple"/></inline-formula> throughout this paper. We also tested different choices of epidemiological parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e302" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e303" xlink:type="simple"/></inline-formula> and obtained qualitatively similar results.) <xref ref-type="fig" rid="pone-0070793-g005">Figures 5</xref> and <xref ref-type="fig" rid="pone-0070793-g006">6</xref> show that even in correlated scale-free networks, with the assumed vaccination coverage <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e304" xlink:type="simple"/></inline-formula> that we tested, results that are qualitatively similar to those in the main text were obtained, i.e., with a low relative cost of treatment, fewer nodes with high degrees are vaccinated, whereas with a high relative cost of treatment, more nodes with high degrees are vaccinated. Therefore, irrespective of the vaccination coverage, the optimal allocations of vaccines show qualitatively similar properties.</p>
<fig id="pone-0070793-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g005</object-id><label>Figure 5</label><caption>
<title>Optimal allocations of vaccines <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e182" xlink:type="simple"/></inline-formula>in correlated scale-free networks with different degree correlations <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e183" xlink:type="simple"/></inline-formula>for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e184" xlink:type="simple"/></inline-formula>.</title>
<p>(a) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e185" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e186" xlink:type="simple"/></inline-formula>; (b) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e187" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e188" xlink:type="simple"/></inline-formula>; (c) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e189" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e190" xlink:type="simple"/></inline-formula>; (d) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e191" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e192" xlink:type="simple"/></inline-formula>; (e) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e193" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e194" xlink:type="simple"/></inline-formula>; (f) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e195" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e196" xlink:type="simple"/></inline-formula>. Other parameters are set to the same values as in Fig. 3. Nodes are grouped into 30 groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g005" position="float" xlink:type="simple"/></fig><fig id="pone-0070793-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070793.g006</object-id><label>Figure 6</label><caption>
<title>Optimal allocations of vaccines <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e197" xlink:type="simple"/></inline-formula>in correlated scale-free networks with different degree correlations <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e198" xlink:type="simple"/></inline-formula> for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e199" xlink:type="simple"/></inline-formula>.</title>
<p>(a) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e200" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e201" xlink:type="simple"/></inline-formula>; (b) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e202" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e203" xlink:type="simple"/></inline-formula>; (c) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e204" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e205" xlink:type="simple"/></inline-formula>; (d) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e206" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e207" xlink:type="simple"/></inline-formula>; (e) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e208" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e209" xlink:type="simple"/></inline-formula>; (f) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e210" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0070793.e211" xlink:type="simple"/></inline-formula>. Other parameters are set to the same values as in Fig. 3. Nodes are grouped into 30 groups.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070793.g006" position="float" xlink:type="simple"/></fig></sec></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0070793-Shulgin1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shulgin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Agur</surname><given-names>Z</given-names></name> (<year>1998</year>) <article-title>Pulse vaccination strategy in the SIR epidemic model</article-title>. <source>Bull Math Biol</source> <volume>60</volume>: <fpage>1123</fpage>–<lpage>1148</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Bauch1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bauch</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Earn</surname><given-names>DJD</given-names></name> (<year>2004</year>) <article-title>Vaccination and the theory of games</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>101</volume>: <fpage>13391</fpage>–<lpage>13394</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Bauch2"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bauch</surname><given-names>CT</given-names></name> (<year>2005</year>) <article-title>Imitation dynamics predict vaccinating behaviour</article-title>. <source>Proc R Soc B</source> <volume>272</volume>: <fpage>1669</fpage>–<lpage>1675</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Perisic1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perisic</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bauch</surname><given-names>CT</given-names></name> (<year>2009</year>) <article-title>A simulation analysis to characterize the dynamics of vaccinating behaviour on contact networks</article-title>. <source>BMC Infect Dis</source> <volume>9</volume>: <fpage>77</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Manfredi1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manfredi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Posta</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>d'Onofrio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Salinelli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Centrone</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Optimal vaccination choice, vaccination games, and rational exemption: an appraisal</article-title>. <source>Vaccine</source> <volume>28</volume>: <fpage>98</fpage>–<lpage>109</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Funk1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Funk</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Salathé</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jansen</surname><given-names>VAA</given-names></name> (<year>2010</year>) <article-title>Modelling the influence of human behavior on the spread of infectious diseases: a review</article-title>. <source>J R Soc Interface</source> <volume>7</volume>: <fpage>1247</fpage>–<lpage>1256</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Wang1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aihara</surname><given-names>K</given-names></name> (<year>2012</year>) <article-title>Safety-information-driven human mobility patterns with metapopulation epidemic dynamics</article-title>. <source>Sci Rep</source> <volume>2</volume>: <fpage>887</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Miller1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Viboud</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Balinska</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Simonsen</surname><given-names>L</given-names></name> (<year>2009</year>) <article-title>The signature features of influenza pandemics-implications for policy</article-title>. <source>N Engl J Med</source> <volume>360</volume>: <fpage>2595</fpage>–<lpage>2598</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Wallinga1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wallinga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Boven</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Optimizing infectious disease interventions during an emerging epidemic</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>107</volume>: <fpage>923</fpage>–<lpage>928</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Medlock1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Medlock</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Galvani</surname><given-names>AP</given-names></name> (<year>2009</year>) <article-title>Optimizing influenza vaccine distribution</article-title>. <source>Science</source> <volume>325</volume>: <fpage>1705</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Liu1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>Toward effective vaccine deployment: a systematic study</article-title>. <source>J Med Syst</source> <volume>35</volume>: <fpage>1153</fpage>–<lpage>1164</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Becker1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Becker</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Starczak</surname><given-names>DN</given-names></name> (<year>1997</year>) <article-title>Optimal vaccination strategies for a community of households</article-title>. <source>Math Biosci</source> <volume>139</volume>: <fpage>117</fpage>–<lpage>132</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Hill1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Longini Jr</surname><given-names>IM</given-names></name> (<year>2003</year>) <article-title>The critical vaccination fraction for heterogeneous epidemic models</article-title>. <source>Math Biosci</source> <volume>181</volume>: <fpage>85</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Bansal1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bansal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pourbohloul</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Meyers</surname><given-names>LA</given-names></name> (<year>2006</year>) <article-title>A comparative analysis of influenza vaccination programs</article-title>. <source>PLoS Med</source> <volume>3</volume>: <fpage>e387</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Tuite1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tuite</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Fisman</surname><given-names>DN</given-names></name>, <name name-style="western"><surname>Kwong</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Greer</surname><given-names>AL</given-names></name> (<year>2010</year>) <article-title>Optimal pandemic influenza vaccine allocation strategies for the canadian population</article-title>. <source>PLoS ONE</source> <volume>5</volume>: <fpage>e10520</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Klepac1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klepac</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Laxminarayan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name> (<year>2011</year>) <article-title>Synthesizing epidemiological and economic optima for control of immunizing infections</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>108</volume>: <fpage>14366</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Patel1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Longini Jr</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Halloran</surname><given-names>ME</given-names></name> (<year>2005</year>) <article-title>Finding optimal vaccination strategies for pandemic influenza using genetic algorithms</article-title>. <source>J Theor Biol</source> <volume>234</volume>: <fpage>201</fpage>–<lpage>212</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Manski1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manski</surname><given-names>CF</given-names></name> (<year>2010</year>) <article-title>Vaccination with partial knowledge of external effectiveness</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>107</volume>: <fpage>3953</fpage>–<lpage>3960</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Latora1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Latora</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Nyamba</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Simpore</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sylvette</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Diane</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Network of sexual contacts and sexually transmitted HIV infection in burkina faso</article-title>. <source>J Med Virol</source> <volume>78</volume>: <fpage>724</fpage>–<lpage>729</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-PastorSatorras1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pastor-Satorras</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vespignani</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>Epidemic spreading in scale-free networks</article-title>. <source>Phys Rev Lett</source> <volume>86</volume>: <fpage>3200</fpage>–<lpage>3203</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-PastorSatorras2"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pastor-Satorras</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vespignani</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>Epidemic dynamics and endemic states in complex networks</article-title>. <source>Phys Rev E</source> <volume>63</volume>: <fpage>066117</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-PastorSatorra1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pastor-Satorra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Vespignani</surname><given-names>A</given-names></name> (<year>2002</year>) <article-title>Immunization of complex networks</article-title>. <source>Phys Rev E</source> <volume>65</volume>: <fpage>036104</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Cohen1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Havlin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>ben Avraham</surname><given-names>D</given-names></name> (<year>2003</year>) <article-title>Efficient immunization strategies for computer networks and populations</article-title>. <source>Phys Rev Lett</source> <volume>91</volume>: <fpage>247901</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Wang2"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xiu</surname><given-names>Z</given-names></name> (<year>2006</year>) <article-title>Entropy optimization of scale-free networks robustness to random failures</article-title>. <source>Physica A</source> <volume>363</volume>: <fpage>591</fpage>–<lpage>596</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Forster1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forster</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Gilligan</surname><given-names>CA</given-names></name> (<year>2007</year>) <article-title>Optimizing the control of disease infestations at the landscape scale</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>104</volume>: <fpage>4984</fpage>–<lpage>4989</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Kleczkowski1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kleczkowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Olés</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gudowska-Nowak</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gilligan</surname><given-names>CA</given-names></name> (<year>2012</year>) <article-title>Searching for the most cost effective strategy for controlling epidemics spreading on regular and small-world networks</article-title>. <source>J R Soc Interface</source> <volume>9</volume>: <fpage>158</fpage>–<lpage>169</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Tanaka1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tanaka</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Morino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Aihara</surname><given-names>K</given-names></name> (<year>2012</year>) <article-title>Dynamical robustness in complex networks: the crucial role of low-degree nodes</article-title>. <source>Sci Rep</source> <volume>2</volume>: <fpage>232</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Gandon1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gandon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mackinnon</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Nee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Read</surname><given-names>AF</given-names></name> (<year>2001</year>) <article-title>Imperfect vaccines and the evolution of pathogen virulence</article-title>. <source>Nature</source> <volume>414</volume>: <fpage>751</fpage>–<lpage>756</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Hoffman1"><label>29</label>
<mixed-citation publication-type="other" xlink:type="simple">Hoffman SL (1996) Malaria vaccine development: a multi-immune response approaches. Washington, D.C.: American Society of Microbiology.</mixed-citation>
</ref>
<ref id="pone.0070793-Blower1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blower</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines</article-title>. <source>AIDS Rev</source> <volume>5</volume>: <fpage>113</fpage>–<lpage>125</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Diekmann1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diekmann</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Heesterbeek</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Metz</surname><given-names>JA</given-names></name> (<year>1990</year>) <article-title>On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations</article-title>. <source>J Math Biol</source> <volume>28</volume>: <fpage>365</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Cohen2"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Erez</surname><given-names>K</given-names></name>, <name name-style="western"><surname>ben Avraham</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Havlin</surname><given-names>S</given-names></name> (<year>2001</year>) <article-title>Breakdown of the internet under intentional attack</article-title>. <source>Phys Rev Lett</source> <volume>86</volume>: <fpage>3682</fpage>–<lpage>3685</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Glover1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Glover</surname><given-names>F</given-names></name> (<year>1990</year>) <article-title>Tabu search: A tutorial</article-title>. <source>Interfaces</source> <volume>20</volume>: <fpage>74</fpage>–<lpage>94</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Molloy1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molloy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Reed</surname><given-names>B</given-names></name> (<year>1995</year>) <article-title>A critical point for random graphs with a given degree sequence</article-title>. <source>Random Struct Algor</source> <volume>6</volume>: <fpage>161</fpage>–<lpage>179</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Liljeros1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liljeros</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Edling</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Amaral</surname><given-names>LAN</given-names></name>, <name name-style="western"><surname>Stanley</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Aberg</surname><given-names>Y</given-names></name> (<year>2001</year>) <article-title>The web of human sexual contacts</article-title>. <source>Nature</source> <volume>411</volume>: <fpage>907</fpage>–<lpage>908</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Huerta1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huerta</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tsimring</surname><given-names>LS</given-names></name> (<year>2002</year>) <article-title>Contact tracing and epidemics control in social networks</article-title>. <source>Phys Rev E</source> <volume>66</volume>: <fpage>056115</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Newman1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Newman</surname><given-names>MEJ</given-names></name> (<year>2002</year>) <article-title>Assortative mixing in networks</article-title>. <source>Phys Rev Lett</source> <volume>89</volume>: <fpage>208701</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Glover2"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Glover</surname><given-names>F</given-names></name> (<year>1989</year>) <article-title>Tabu search-part I. ORSA Journal on Computing</article-title>. <volume>1</volume>: <fpage>190</fpage>–<lpage>206</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Glover3"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Glover</surname><given-names>F</given-names></name> (<year>1990</year>) <article-title>Tabu search-part II</article-title>. <source>ORSA Journal on Computing</source> <volume>2</volume>: <fpage>4</fpage>–<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Ji1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ji</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name> (<year>2004</year>) <article-title>Global optimizations and tabu search based on memory</article-title>. <source>Appl Math Comput</source> <volume>159</volume>: <fpage>449</fpage>–<lpage>457</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070793-Wang3"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xiu</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>BJ</given-names></name> (<year>2007</year>) <article-title>Optimal synchronizability of networks</article-title>. <source>Eur Phys J B</source> <volume>60</volume>: <fpage>89</fpage>–<lpage>95</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>